Reports on H1N1 By The CDC Are
Designed To Withhold Key Information
The failure of the CDC to report critical changes of the H1N1
virus and its effective transmission, indicates their weekly reports
are carefully designed to withhold key information.
A recent spike in cases with antiviral resistance have been reported
in the U.S. Of the 29 total cases identified, 19 patients had
documented exposure to Tamiflu through either treatment or chemoprophylaxis.
Of the cases identified, 16 of them have come in the past 4 weeks,
which is much higher than previous weeks, which were typically
This recent spike in cases has also been reported by WHO and raises
concerns that an upgraded form of the H1N1 virus efficiently transmitting.
Moreover, recent deaths of patients with the upgraded form in
the US (four of ten) and the Netherlands (four of eleven) have
raised concerns that these patients may also have inherited other
changes to the virus which have been associated with fatal cases
in the US, Ukraine, Norway, Brazil, and France.
However, the CDC report does address those concerns. They do not
distinguish between these recent samples and those collected in
the spring or summer. Similarly, the location of these cases or
outcomes are not made public, and there is no differentiation
between patients who developed resistance during treatment and
patients who were resistant prior to treatment. They only classify
"suspect" cases on the basis that they failed to respond
to Tamiflu which conveniently leaves the issue interpretation
by other experts and agencies.
The Vietnam cluster described
in this week's New England Journal of Medicine would represent
such cases. Seven passengers on a train developed H1N1 infections
that had the resistant strain. However, like most patients worldwide,
the resistance was not discovered until long after treatment and
discharge. The infections were in July, but the first lab confirmations
were in September. Although Tamiflu treatment is not effective
against H1N1 with the resistant strains (H275Y/H274Y), all patients
recovered, but clearly represented infections of a fit and readily
transmissible version of H1N1.
However, using the CDC classification system, these patients
would have "documented exposure to Tamiflu" but would
not be examples of resistance that developed due to treatment.
Although this is the CDC's largest category, they have yet to
show a single example of a case that developed resistance after
treatment with Tamiflu.
The failure of the CDC to report critical information such as
changes to the virus and resistance to treatment raise concerns
that the weekly reports by the CDC are carefully designed to withhold
key information, including status prior to treatment, the dates
and locations of samples, as well as outcomes of patients who
are positive for H1N1 resistant strains.
In early November, the CDC and World Health Organization (WHO)
were strongly criticized for manipulatiing swine flu deaths by
stating that 4,000 Americans - rather than about 1,200 - had died
of swine flu since the disease emerged in April. That new estimate
by the CDC combined deaths from laboratory-confirmed cases of
the flu and deaths that appeared to be brought on by flu, even
though the patients may have ultimately died of bacterial pneumonia,
other infections or organ failure.
This intrinsic manipulation and lack of transparency by the CDC
continues to be hazardous to the world's health.
Reference Source 133, 172, 242, 243
December 14, 2009